Literature DB >> 9704793

The optimal route of delivery for fetal meningomyelocele.

D C Merrill1, P Goodwin, J M Burson, Y Sato, R Williamson, C P Weiner.   

Abstract

OBJECTIVE: It has been proposed that cesarean section improves the long-term neurologic outcome of children with meningomyelocele. On the basis of this belief, a trial of labor is not offered in many centers. We hypothesized that there is no difference in immediate or long-term outcome by route of delivery for the fetus with meningomyelocele delivered in a tertiary care center. STUDY
DESIGN: All fetuses (n = 60) with meningomyelocele delivered at the University of Iowa Hospitals and Clinics between 1971 and 1995 were analyzed. Thirty-six cases were available for long-term follow-up. Motor, sensory, and anatomic levels were converted to a numeric scale. Variables were compared by one-way analysis of variance, chi2 analysis, and Fisher's exact test with significance at P < .05.
RESULTS: There were no significant differences by route of delivery for gestational age of delivery, birth weight, meningomyelocele size, or neonatal mortality (vaginal: 1/22 = 4.5%, cesarean section: 2/17 = 11.8%, P = .82). An antenatal diagnosis was made with similar frequency in the two groups (vaginal: 15/21 = 71.4%, cesarean section: 13/15 = 86.7%). In addition, the length of long-term follow-up was similar (vaginal: 54.7 +/- 11.1 months, cesarean section: 33.7 +/- 8.6 months). There was no difference in long-term neurologic outcome as determined by the change in motor level, the change in sensory level, or when comparing the final motor level with the anatomic level.
CONCLUSIONS: This study was unable to detect differences between either immediate or long-term outcome for the infant with isolated meningomyelocele when stratified by route of delivery. A multicenter randomized trial should be required before the acceptance of cesarean section as the optimal route of delivery for the fetus with meningomyelocele.

Entities:  

Mesh:

Year:  1998        PMID: 9704793     DOI: 10.1016/s0002-9378(98)70278-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  In utero Repair of Myelomeningocele: Rationale, Initial Clinical Experience and a Randomized Controlled Prospective Clinical Trial.

Authors:  Enrico Danzer; Alan W Flake
Journal:  Neuroembryology Aging       Date:  2008-02-26

2.  Mortality by mode of delivery among infants with spina bifida in Texas.

Authors:  Renata H Benjamin; Adriana Lopez; Laura E Mitchell; KuoJen Tsao; Anthony Johnson; Peter H Langlois; Michael D Swartz; A J Agopian
Journal:  Birth Defects Res       Date:  2019-10-23       Impact factor: 2.344

Review 3.  Fetal surgery for spina bifida: past, present, future.

Authors:  N Scott Adzick
Journal:  Semin Pediatr Surg       Date:  2013-02       Impact factor: 2.754

Review 4.  Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention.

Authors:  N Scott Adzick
Journal:  Semin Fetal Neonatal Med       Date:  2009-06-18       Impact factor: 3.926

Review 5.  Epidemiology, prenatal management, and prevention of neural tube defects.

Authors:  Mustafa A Salih; Waleed R Murshid; Mohammed Z Seidahmed
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

6.  Perinatal and Neonatal Outcomes of Patients Who Were Diagnosed with Neural Tube Defect in Midtrimester Fetal Ultrasound Scan and Refused Request for Termination of Pregnancy.

Authors:  Rauf Melekoglu; Sevil Eraslan; Ebru Celik; Yavuz Simsek
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.